Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-11

Clinical Trial Update: Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated the combination of fludarabine and darbepoetin alfa in older patients with chronic lymphocytic leukemia and anemia. The study has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fludarabine (Fludarabine)
  • darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: German CLL Study Group | Conditions: Chronic Lymphocytic Leukemia, Anemia | Phase 3 | Status: COMPLETED